LeukoDx Retains thinXXS to Develop Its Microfluidics Cartridge

TOWSON, MD and JERUSALEM and ZWEIBRUCKEN, GERMANY--(Marketwire - November 17, 2010) - LeukoDx Inc. is pleased to announce today that it has retained the services of thin XXS Microtechnology AG to develop the single use microfluidics cartridge to be used in its Point of Care micro-flow cytometry platform. LeukoDx is focused on exploiting the power of flow cytometry and dramatically expanding its use for diagnostics by developing affordable and simple to use micro-flow cytometer systems. The Point of Care systems developed by LeukoDx combine a small footprint reading instrument and compact single use test cartridges. LeukoDx is currently focused on developing a sepsis diagnosis and monitoring test based on CD64 neutrophil activation, an early and specific sepsis marker. http://www.marketwire.com/press-release/LeukoDx-Retains-thinXXS-to-Develop-Its-Microfluidics-Cartridge-1355021.htm